Bruton tyrosine kinase inhibitor
C10036
concept
A Bruton tyrosine kinase inhibitor is a targeted small-molecule drug that blocks BTK signaling in B cells to disrupt pathways critical for their activation, proliferation, and survival, primarily used in the treatment of certain B-cell malignancies and autoimmune diseases.
All labels observed (4)
| Label | Occurrences |
|---|---|
| Bruton tyrosine kinase inhibitor canonical | 4 |
| Bruton’s tyrosine kinase inhibitor | 1 |
| non-covalent BTK inhibitor | 1 |
| second-generation BTK inhibitor | 1 |
Description generation (CDg)
The one-sentence description above was generated by prompting gpt-5.1 with the class name and this instruction.
Instruction
generate a one-sentence description for a given conceptual class. # Response Format Return only the sentence: "Description: [one-sentence description of the conceptional class]"
Input
Class: Bruton tyrosine kinase inhibitor
Generated description
A Bruton tyrosine kinase inhibitor is a targeted small-molecule drug that blocks BTK signaling in B cells to disrupt pathways critical for their activation, proliferation, and survival, primarily used in the treatment of certain B-cell malignancies and autoimmune diseases.
Instances (5)
| Instance | Via concept surface |
|---|---|
| Imbruvica | — |
| LOXO-305 | Bruton’s tyrosine kinase inhibitor |
| acalabrutinib | — |
| pirtobrutinib | — |
| zanubrutinib | — |